Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Influential and impactful Oxford Self-harm Monitoring System had been in place, and continuously funded, for 50 years.

Dozens of participants seated and standing at the event in the Seminar Room at the Department of Psychiatry to mark 50 years of the Oxford Self-harm Monitoring System. Emeritus Professor Keith Hawton is pictured third from right on the front row.

A one-day meeting was held in the Department of Psychiatry on Wednesday 16 April to mark the fact that at the end of 2025 the Oxford Self-harm Monitoring System had been in place, and continuously funded, for 50 years.

The Monitoring System involves data collection by clinical staff working in the Emergency Department at the John Radcliffe Hospital on all individuals who present with self-harm (self-poisoning or self-injury). This currently involves approximately 2,000 episodes per year. The data is used for a wide range of research projects, including within the Multicentre Study of Self-harm in England.

The Monitoring System was established as a research database by Emeritus Professor of Psychiatry, Keith Hawton, when he was a junior member of the Department in the 1970s. He directed this work until 2023, following which Professor Seena Fazel took over the leadership.

Head of the Department of Psychiatry at Oxford, Professor Belinda Lennox opened the meeting by welcoming everyone and highlighting the importance of the Monitoring System for research in the Department. Professor Sir Louis Appleby, who leads the National Suicide Prevention Strategy for England and the National Inquiry into Suicide and Safety in Mental Health, gave an account of the role of the research from the Monitoring System in relation to national policy regarding management and prevention of self-harm.

Read the full story on the Department of Psychiatry website.

 

Similar stories

First clinical study in GSK-Oxford Experimental Medicine Collaboration starts as first patient dosed in ulcerative colitis experimental trial

The first patient in the PEGASUS clinical study, part of the GSK-University of Oxford Experimental Medicine Collaboration, received the first dose last week, on 8 October 2026.

Wearable chest patch could support hospital-level care at home, study finds

Researchers in Oxford have shown that wearable chest patches can be used to effectively monitor vital signs in many acutely unwell patients receiving hospital-level care in their own homes.

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Phase I clinical study of ChAdOx1 BDBV vaccine launches in Uganda

The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine (MRC/UVRI & LSHTM Uganda Research Unit) has launched a Phase I clinical study evaluating the safety and immunogenicity of a candidate vaccine against Bundibugyo virus disease (BVD), a severe form of Ebola virus disease caused by Bundibugyo virus (BDBV), in partnership with the University of Oxford.

The Nuffield Department of Women's & Reproductive Health's Clinical Research Group recruits its 2,000th participant to the Generation Study

Oxford’s Clinical Research Group (CRG) has reached an important milestone after recruiting its 2,000th participant to the nationwide Generation Study.

Dementias Platform UK (DPUK) blood biomarker project takes next step towards NHS dementia diagnosis

A project involving researchers from the Universities of Oxford and Cambridge, Imperial College London and Dementias Platform UK (DPUK) has been selected for a major UK initiative aimed at improving dementia diagnosis and helping more people access the support and treatment they need sooner.